Global Pril-series Drugs API Market Growth 2024-2030

Global Pril-series Drugs API Market Growth 2024-2030

Pril-series drugs are one of the commonly used antihypertensive drugs in clinical practice, ending with "Pril", such as perindopril and enalapril. Pril-series drugs are called Angiotensin-converting enzyme (ACE) inhibitors, are medicines that help relax the veins and arteries to lower blood pressure.

The global Pril-series Drugs API market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Pril-series Drugs API Industry Forecast” looks at past sales and reviews total world Pril-series Drugs API sales in 2023, providing a comprehensive analysis by region and market sector of projected Pril-series Drugs API sales for 2024 through 2030. With Pril-series Drugs API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pril-series Drugs API industry.

This Insight Report provides a comprehensive analysis of the global Pril-series Drugs API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pril-series Drugs API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pril-series Drugs API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pril-series Drugs API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pril-series Drugs API.

United States market for Pril-series Drugs API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Pril-series Drugs API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Pril-series Drugs API is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Pril-series Drugs API players cover Huahai Pharmaceutical, Zhejiang Changming Pharmaceutical, Dr. Reddy's Laboratories, Glenmark, ScinoPharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Pril-series Drugs API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Enalapril
Lisinopril
Captopril
Ramipril
Perindopril
Benazepril
Others

Segmentation by Application:
Tablets
Capsules
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Huahai Pharmaceutical
Zhejiang Changming Pharmaceutical
Dr. Reddy's Laboratories
Glenmark
ScinoPharm
Novartis Pharma
Sun Pharmaceutical
Farmhispania
Medichem
Hetero
Siegfried Evionnaz
Changzhou Pharmaceutical Factory
Chongqing Southwest No. 2 Pharmaceutical Factory
Ningbo Menovo Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pril-series Drugs API market?

What factors are driving Pril-series Drugs API market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pril-series Drugs API market opportunities vary by end market size?

How does Pril-series Drugs API break out by Type, by Application?



Please note: The report will take approximately 2 business days to prepare and deliver.